The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

Choosing Your MedsChoosing Your Meds
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  • Email Email
  • Glossary Glossary

Starting treatment

Aug 12, 2012

Hello I am soon to start treatment. My last cd4 count was 554 and VL was about 10,000. My Doctor has recommended Kivexa and Nevirapine. I have done the HLA-B*5701 test and all is OK for me to take these drugs. Is this a preferred or recommended combination? No one I know who is HIV+ is on either of these drugs.

Response from Dr. Young

Hello and thanks for posting.

I have a mixed opinion about your proposed regimen. With a negative HLA test, Kivexa (we call it Epzicom here) is a very reasonable option. Kivexa is part of the recommended first line NRTI options in the July 2012 IAS-USA Treatment Guidelines and used commonly in many places. On the other hand, nevirapine is an acceptable option, but should be avoided in persons (like you) with normal-range CD4 cell counts, because of an increased risk of developing a serious liver toxicity.

I'd suggest asking your doctor about the choices in your regimen and why the nevirapine was selected over other more recommended first-line components to pair with the NRTIs (Kivexa), like efavirenz, boosted protease inhibitor or integrase inhibitor.

I hope that helps, BY

Thanks for your precious time Dr. Young.
Does PEP work if taken less than 28 days?

  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint